| Financial Year |
March 31 2023 |
| Monetary Funds |
3,271,311,773.93 |
| Held-for-trading Financial Assets |
4,808,439,257.33 |
| Notes Receivable |
5,216,994.00 |
| Accounts Receivable |
2,105,090,034.08 |
| Advances to Suppliers |
36,903,570.16 |
| Other Receivables |
752,126,009.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,071,078.36 |
| Dividend Receivable |
2,525,652.13 |
| Inventories |
1,771,339,339.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
194,568,126.11 |
| Other Current Assets |
205,366,689.48 |
| Total Current Assets |
18,306,720,366.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,353,251,151.35 |
| Long-term Equity Investment |
948,130,238.57 |
| Investment Properties |
1,882,377,699.71 |
| Fixed Assetes |
222,604,981.14 |
| Under-construction Projects |
593,965.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
389,655,422.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
23,748,653.46 |
| Deferred Income Tax Assets |
97,298,996.72 |
| Other Non-Current Assets |
2,196,713,927.22 |
| Sub-Total of Non-Current Assets |
7,941,916,951.07 |
| Total Assets |
26,248,637,317.74 |
| Short-Term Loans |
150,119,166.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,881,214.34 |
| Accounts Payable |
12,901,225,024.61 |
| Accounts Received In Advance |
774,323.78 |
| Employee Compensation Payable |
230,922,455.35 |
| Taxes Payable |
37,459,663.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
96,050,107.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
34,555,254.29 |
| Other Current Liabilities |
536,269,118.75 |
| Sub-Total of Current Liabilities |
15,439,532,800.87 |
| Long-term Loans |
56,720,000.00 |
| Bonds Payable |
2,800,478,166.69 |
| Long-Term Accounts Payable |
271,005,753.97 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
28,667,415.24 |
| Other Non-Current Liabilities |
247,875,774.91 |
| Sub-Total of Non-Current Liabilities |
3,419,904,076.32 |
| Total Liabilities |
18,859,436,877.19 |
| Paid-In Capital(Or Share Stock) |
970,256,000.00 |
| Capital Surplus |
1,990,040,174.62 |
| Surplus Reserve |
504,044,261.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,832,647,968.35 |
| Minority Stockholder's Interest |
84,557,224.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,304,643,215.92 |
| Owner's Equity（Stockholder's Equity） |
7,389,200,440.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,248,637,317.74 |
